Formulation code
Absolute bioavailability (μg/ml)
Relative bioavailability (μg/ml)
Area under curve (0-8) (μg/ml.hrs)
Cmax (μg/ml)
Tmax (hrs.)
Oral control group
----
----
802.8
5.849± 0.245
2
IV control group
----
----
986.7
9.546± 0.094
5
a
F
1
0.826
1.015
815.3
6.325± 0.324
2
F
2
0.821
1.010
810.9
5.590± 0.432
2
SD is standard deviation for n = 3 observations
Table 3:
Comparison for bioavailability of lovastatin nanocrystal.
